p53-binding proteins in squamous cell carcinoma and normal human keratinocytes

M. G. Kumar, Dan Spandau

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

In squamous cell carcinomas (SCCs), the tumor suppressor protein p53 is frequently overexpressed. The overexpression of p53 is often due to a mutation in the p53 gene; however, increased levels of p53 protein can be observed in the tumors without p53 gene mutations. In normal human keratinocytes, p53 is a multiconformational protein. The different conformations of p53 can be identified by their reactivity with epitope- specific, anti-p53 monoclonal antibodies. This study provides evidence that the different p53 conformations seen in human keratinocytes bind to distinct cellular proteins. Proteins that bind p53 in normal human keratinocytes were compared with p53-binding proteins from cells derived from SCC tumors by immunoprecipitation of [35S]methionine-labeled and 32P(i)-labeled cell lysates using a panel of anti-p53 monoclonal antibodies. In one tumor, the SCC cells contained a protein of M(r) 30,000 bound to p53 that was not seen in normal human keratinocytes. Cells derived from a separate SCC did not have the M(r) 30,000 protein but did contain two proteins of M(r) 15,000 and M(r) 16,000, which were not seen in normal human keratinocytes. The immunofluorescent staining pattern of cultured normal human keratinocytes, cells derived from two SCCs, as well as the original tumors from which the cells were derived, was also examined. The immunofluorescent staining of the cells derived from the tumors and the tumors themselves was different from that seen in normal cultured keratinocytes and normal epidermis. These studies suggest that there are alterations in the proteins that bind to p53 in SCCs.

Original languageEnglish
Pages (from-to)1601-1608
Number of pages8
JournalCell Growth and Differentiation
Volume6
Issue number12
StatePublished - 1995

Fingerprint

Keratinocytes
Squamous Cell Carcinoma
Carrier Proteins
Proteins
Neoplasms
p53 Genes
Monoclonal Antibodies
Staining and Labeling
Tumor Suppressor Protein p53
Mutation
Immunoprecipitation
Epidermis
Methionine
Epitopes

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

p53-binding proteins in squamous cell carcinoma and normal human keratinocytes. / Kumar, M. G.; Spandau, Dan.

In: Cell Growth and Differentiation, Vol. 6, No. 12, 1995, p. 1601-1608.

Research output: Contribution to journalArticle

@article{d709b6ace0734616b98740cd0aa52505,
title = "p53-binding proteins in squamous cell carcinoma and normal human keratinocytes",
abstract = "In squamous cell carcinomas (SCCs), the tumor suppressor protein p53 is frequently overexpressed. The overexpression of p53 is often due to a mutation in the p53 gene; however, increased levels of p53 protein can be observed in the tumors without p53 gene mutations. In normal human keratinocytes, p53 is a multiconformational protein. The different conformations of p53 can be identified by their reactivity with epitope- specific, anti-p53 monoclonal antibodies. This study provides evidence that the different p53 conformations seen in human keratinocytes bind to distinct cellular proteins. Proteins that bind p53 in normal human keratinocytes were compared with p53-binding proteins from cells derived from SCC tumors by immunoprecipitation of [35S]methionine-labeled and 32P(i)-labeled cell lysates using a panel of anti-p53 monoclonal antibodies. In one tumor, the SCC cells contained a protein of M(r) 30,000 bound to p53 that was not seen in normal human keratinocytes. Cells derived from a separate SCC did not have the M(r) 30,000 protein but did contain two proteins of M(r) 15,000 and M(r) 16,000, which were not seen in normal human keratinocytes. The immunofluorescent staining pattern of cultured normal human keratinocytes, cells derived from two SCCs, as well as the original tumors from which the cells were derived, was also examined. The immunofluorescent staining of the cells derived from the tumors and the tumors themselves was different from that seen in normal cultured keratinocytes and normal epidermis. These studies suggest that there are alterations in the proteins that bind to p53 in SCCs.",
author = "Kumar, {M. G.} and Dan Spandau",
year = "1995",
language = "English",
volume = "6",
pages = "1601--1608",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "12",

}

TY - JOUR

T1 - p53-binding proteins in squamous cell carcinoma and normal human keratinocytes

AU - Kumar, M. G.

AU - Spandau, Dan

PY - 1995

Y1 - 1995

N2 - In squamous cell carcinomas (SCCs), the tumor suppressor protein p53 is frequently overexpressed. The overexpression of p53 is often due to a mutation in the p53 gene; however, increased levels of p53 protein can be observed in the tumors without p53 gene mutations. In normal human keratinocytes, p53 is a multiconformational protein. The different conformations of p53 can be identified by their reactivity with epitope- specific, anti-p53 monoclonal antibodies. This study provides evidence that the different p53 conformations seen in human keratinocytes bind to distinct cellular proteins. Proteins that bind p53 in normal human keratinocytes were compared with p53-binding proteins from cells derived from SCC tumors by immunoprecipitation of [35S]methionine-labeled and 32P(i)-labeled cell lysates using a panel of anti-p53 monoclonal antibodies. In one tumor, the SCC cells contained a protein of M(r) 30,000 bound to p53 that was not seen in normal human keratinocytes. Cells derived from a separate SCC did not have the M(r) 30,000 protein but did contain two proteins of M(r) 15,000 and M(r) 16,000, which were not seen in normal human keratinocytes. The immunofluorescent staining pattern of cultured normal human keratinocytes, cells derived from two SCCs, as well as the original tumors from which the cells were derived, was also examined. The immunofluorescent staining of the cells derived from the tumors and the tumors themselves was different from that seen in normal cultured keratinocytes and normal epidermis. These studies suggest that there are alterations in the proteins that bind to p53 in SCCs.

AB - In squamous cell carcinomas (SCCs), the tumor suppressor protein p53 is frequently overexpressed. The overexpression of p53 is often due to a mutation in the p53 gene; however, increased levels of p53 protein can be observed in the tumors without p53 gene mutations. In normal human keratinocytes, p53 is a multiconformational protein. The different conformations of p53 can be identified by their reactivity with epitope- specific, anti-p53 monoclonal antibodies. This study provides evidence that the different p53 conformations seen in human keratinocytes bind to distinct cellular proteins. Proteins that bind p53 in normal human keratinocytes were compared with p53-binding proteins from cells derived from SCC tumors by immunoprecipitation of [35S]methionine-labeled and 32P(i)-labeled cell lysates using a panel of anti-p53 monoclonal antibodies. In one tumor, the SCC cells contained a protein of M(r) 30,000 bound to p53 that was not seen in normal human keratinocytes. Cells derived from a separate SCC did not have the M(r) 30,000 protein but did contain two proteins of M(r) 15,000 and M(r) 16,000, which were not seen in normal human keratinocytes. The immunofluorescent staining pattern of cultured normal human keratinocytes, cells derived from two SCCs, as well as the original tumors from which the cells were derived, was also examined. The immunofluorescent staining of the cells derived from the tumors and the tumors themselves was different from that seen in normal cultured keratinocytes and normal epidermis. These studies suggest that there are alterations in the proteins that bind to p53 in SCCs.

UR - http://www.scopus.com/inward/record.url?scp=0028864154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028864154&partnerID=8YFLogxK

M3 - Article

C2 - 9019165

AN - SCOPUS:0028864154

VL - 6

SP - 1601

EP - 1608

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 12

ER -